Results 81 to 90 of about 10,211 (127)

Prevalence of Chlamydia trachomatis in an asymptomatic female population attending cervical cytology services of three healthcare centers in Medellín, Colombia [PDF]

Biomedica, 2020
Orozco-Hoyos N, Baena A, Montoya-Ruiz C, Sánchez GI, Restrepo E.   +4 more
europepmc   +1 more source

Risk factors for candidemia: a prospective matched case-control study. [PDF]

Crit Care, 2020
Poissy J, Damonti L, Bignon A, Khanna N, Von Kietzell M, Boggian K, Neofytos D, Vuotto F, Coiteux V, Artru F, Zimmerli S, Pagani JL, Calandra T, Sendid B, Poulain D, van Delden C, Lamoth F, Marchetti O, Bochud PY, FUNGINOS, Allfun French Study Groups.   +20 more
europepmc   +1 more source

COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer. [PDF]

Br J Cancer
Segal NH, Tie J, Kopetz S, Ducreux M, Chen E, Dienstmann R, Hollebecque A, Reilley MJ, Elez E, Cosaert J, Cain J, Soo-Hoo Y, Hewson N, Cooper ZA, Kumar R, Tabernero J.   +15 more
europepmc   +1 more source

Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution? [PDF]

PLoS One, 2020
Boiza-Sánchez M, Manso R, Balagué O, Chamizo C, Askari E, Salgado RN, Blas-López C, Aguirregoicoa-García E, Menárguez J, Santonja C, Adrados M, Limeres-González MÁ, Piris MÁ, Rodríguez-Pinilla SM.   +13 more
europepmc   +1 more source

Pembrolizumab plus either epacadostat or placebo for cisplatin-ineligible urothelial carcinoma: results from the ECHO-307/KEYNOTE-672 study. [PDF]

BMC Cancer
Necchi A, Van der Heijden MS, Trukhin D, Peer A, Gurney H, Alekseev BY, Parnis FX, Leibowitz R, De Santis M, Grivas P, Clark J, Munteanu M, Kataria R, Jia C, Balar AV, de Wit R.   +15 more
europepmc   +1 more source

Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development. [PDF]

Mol Cancer
Vasseur D, Bigot L, Beshiri K, Flórez-Arango J, Facchinetti F, Hollebecque A, Tselikas L, Aldea M, Blanc-Durand F, Gazzah A, Planchard D, Lacroix L, Pata-Merci N, Nobre C, Da Silva A, Nicotra C, Ngo-Camus M, Braye F, Nikolaev SI, Michiels S, Jules-Clement G, Olaussen KA, André F, Scoazec JY, Barlesi F, Ponce S, Soria JC, Besse B, Loriot Y, Friboulet L.   +29 more
europepmc   +1 more source

Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients. [PDF]

NPJ Precis Oncol
Vasseur D, Arbab A, Giudici F, Marzac C, Michiels S, Tagliamento M, Bayle A, Smolenschi C, Sakkal M, Aldea M, Sassi H, Dall'Olio FG, Pata-Merci N, Cotteret S, Fiévet A, Auger N, Friboulet L, Facchinetti F, Géraud A, Ponce S, Hollebecque A, Besse B, Micol JB, Italiano A, Lacroix L, Rouleau E.   +25 more
europepmc   +1 more source

First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort. [PDF]

JHEP Rep
Adamus N, Edeline J, Henriques J, Fares N, Lecomte T, Turpin A, Vernerey D, Vincens M, Chanez B, Tougeron D, Tournigand C, Assenat E, Delaye M, Manfredi S, Bouché O, Williet N, Vienot A, Blaise L, Mas L, Neuzillet C, Boilève A, Roth GS.   +21 more
europepmc   +1 more source

CD8 T cells are dispensable for experimental autoimmune prostatitis induction and chronic pelvic pain development. [PDF]

Front Immunol
Salazar FC, Martinez MS, Paira DA, Chocobar YA, Olivera C, Godoy GJ, Acosta-Rodriguez EV, Rivero VE, Motrich RD.   +8 more
europepmc   +1 more source

Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV. [PDF]

PLoS Biol, 2020
Kusejko K, Günthard HF, Olson GS, Zens K, Darling K, Khanna N, Furrer H, Vetter P, Bernasconi E, Vernazza P, Hoffmann M, Kouyos RD, Nemeth J, Swiss HIV Cohort Study.   +13 more
europepmc   +1 more source